| Patents for C07J 5 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, and substituted in position 21 by only one singly bound oxygen atom (1,937) |
|---|
| 01/13/2005 | US20050009798 Carbonate and carbamate modified forms of glucocorticoids in combination with B2 adrenergic agonists |
| 01/13/2005 | US20050009796 Use of pregnane-diones or diols as neuropathic analgesic agents |
| 01/12/2005 | EP1496064A1 Nitrate active principle |
| 12/30/2004 | US20040266742 Combination therapy of an sodm and a corticosteroid for prevention and/or treatment of inflammatory disease |
| 12/28/2004 | US6835724 Corticoid 17,21-dicarboxylic esters and corticosteroid 17-carboxylic ester 21-carbonic esters, processes for their preparation and pharmaceuticals containing these compounds |
| 12/23/2004 | WO2004094451A3 8$G(B)-VINYL-11$G(B)-($G(V)-SUBSTITUTED)ALKYL-ESTRA-1,3,5(10)-TRIENES |
| 12/15/2004 | EP0837874B1 Neuroactive steroids of the androstane and pregnane series |
| 12/09/2004 | US20040248870 High-purity composition comprising (7alpha, 17alpha)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-one and a process for purifying (7alpha, 17alpha)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-one |
| 12/09/2004 | US20040248868 Antiischemic agents; prevent damage to tissues, organs |
| 12/07/2004 | US6828120 Preparation of 11 beta ,17 alpha ,21- trihydroxy-6 alpha -methylpregna-1,4-diene-3,20-dione 21-acetate; obtain chemical intermediates, incubate reaction mix and enzymes, recover product |
| 11/25/2004 | US20040235811 For therapy of rhinitis and asthma, particularly by inhalation, and for treating inflammation, particularly by local or topical administration |
| 11/25/2004 | DE10318896A1 8beta-Vinyl-11beta-(omega-substituierte)alkyl-estra-1,3,5(10)-triene 8beta-vinyl-11beta- (omega-substituted) alkyl-estra-1,3,5 (10) -trienes |
| 11/24/2004 | CN1549719A Use of pregnane-diones or diols as neuropathic analgesic agents |
| 11/18/2004 | WO2004078102A3 Sterilization of beclomethasone drug particles for pulmonary delivery |
| 11/11/2004 | WO2004066920A3 17-carbamoyloxy cortisol derivatives as selective glucocorticoid receptor modulators |
| 11/10/2004 | EP1474435A1 Process for the preparation of pregnanes |
| 11/04/2004 | WO2004094451A2 8$G(B)-VINYL-11$G(B)-($G(V)-SUBSTITUTED)ALKYL-ESTRA-1,3,5(10)-TRIENES |
| 11/04/2004 | CA2522354A1 8beta-vinyl-11beta-(alpha-substituted)alkyl-estra-1,3,5(10)-trienes |
| 11/03/2004 | CN1173702C Glucocorticoid containing pharmaceutical inhalant powder and method for sterilizing the powder |
| 10/27/2004 | EP1470151A1 Process for the preparation of 7-alpha-methylsteroids |
| 10/27/2004 | CN1541220A 17 alfa, 21-dihydroxypregnene esters as antiandrogenic agents |
| 10/21/2004 | WO2004089970A2 Crystalline 19-norsteroids |
| 10/19/2004 | CA2113404C 17,20-epoxide derivatives of pregnane, their preparation and their application to the preparation of cortisone derivatives and intermediates |
| 10/13/2004 | EP1465855A2 Method for the production of 6-alpha-fluoro corticosteroids |
| 10/13/2004 | EP1465619A1 Suppression of cartilage degradation via the estrogen receptor |
| 10/05/2004 | CA2113776C Novel process for the preparation of 16.alpha.-methylated steroids |
| 09/30/2004 | WO2004033478A3 Fatty acid modified forms of glucocorticoids and their use as anti-inflammatory |
| 09/29/2004 | EP0969813B1 Topical pharmaceutical composition comprising a cholinergic agent or a calcium channel blocker |
| 09/22/2004 | CN1531544A Preparation of fluorine compound and its 17-carboxyl androstene analog |
| 09/16/2004 | WO2004078774A1 Process for the production of tibolone |
| 09/16/2004 | WO2004078102A2 Sterilization of beclomethasone drug particles for pulmonary delivery |
| 09/16/2004 | US20040181055 Stereoselective process for the production of 6alpha-fluorpregnanes and intermediates |
| 09/16/2004 | CA2517934A1 Process for the production of tibolone |
| 09/08/2004 | EP1454636A1 Sterilization of glucocorticoid drug particles for pulmonary delivery |
| 09/08/2004 | EP1347744B1 Solid dispersions of nitrate active principles |
| 09/02/2004 | WO2004074306A1 A continuous process for the production of r-rofleponide |
| 09/01/2004 | EP1450817A1 Use of pregnane-diones or diols as neuropathic analgesic agents |
| 08/31/2004 | US6784170 Synthesis of anti-estrogenic and other therapeutic steroids from 21-hydroxy-19-norpregna-4-en-3-one |
| 08/25/2004 | EP1003553B1 The use of angiostatic steroids in photodynamic therapy |
| 08/12/2004 | WO2004067546A1 Carboxylic-acid-ester-type tetraalkyl ammonium salts, method for the production thereof and pharmaceutical compositions containing said compounds |
| 08/12/2004 | WO2004066920A2 17-carbamoyloxy cortisol derivatives as selective glucocorticoid receptor modulators |
| 08/10/2004 | CA2102400C Method for making 3.alpha.-hydroxy, 3.beta.-substituted-pregnanes |
| 07/29/2004 | DE10303669A1 New quaternary ammonioalkyl carbonate esters useful for treating bacterial and fungal infections and potentially useful for regulating cholesterol biosynthesis |
| 07/28/2004 | EP0823897B1 Nicotinic acid esters and pharmaceutical compositions containing them |
| 07/28/2004 | EP0823895B1 Fatty acid esters as bioactive compounds |
| 07/28/2004 | CN1515261A Topical medicine composite containing cholinergic drug or calcium channel paralyser |
| 07/27/2004 | US6767904 Steroid derived antibiotics |
| 07/27/2004 | US6767903 New7α, 17α-bis-alkylated testosterone derivatives and their use in long-term therapy of androgen-dependent diseases |
| 07/21/2004 | CN1514735A Ophthalmic composition comprising hyaluronic acid |
| 07/15/2004 | WO2004011663A3 Microbiological method for the production of 7 alpha-substituted 11 alpha-hydroxysteroids |
| 07/13/2004 | US6762175 Fatty acid derivatives |
| 07/01/2004 | US20040127472 Use of anecortave acetate for the protection of visual acuity in patients with age related macular degeneration |
| 06/24/2004 | WO2004052911A1 Process for the preparation of pregnanes |
| 06/16/2004 | EP0977725B1 New fatty acid derivatives |
| 06/10/2004 | WO2004047845A1 CARBONATE AND CARBAMATE MODIFIED FORMS OF GLUCOCORTICOIDS IN COMBINATION WITH β2 ADRENERGIC AGONISTS |
| 05/27/2004 | US20040102425 Selective glucocorticoid receptor agonists |
| 05/26/2004 | EP1422235A1 Stereoselective method of producing 6alpha-fluoropregnanes and intermediaries |
| 05/26/2004 | EP1421099A1 17alfa, 21-dihydroxypregnene esters as antiandrogenic agents |
| 05/26/2004 | EP0740650B1 Codrugs as a method of controlled drug delivery |
| 05/25/2004 | CA2153681C Topical ketoconazole compositions |
| 05/25/2004 | CA2149777C New steroids |
| 05/12/2004 | EP1416938A1 Delayed and sustained drug release |
| 05/12/2004 | EP1416937A1 Prophylactic and therapeutic use of hydroxysteroids |
| 05/12/2004 | CN1149222C Preparation of furoic acid momisone |
| 05/06/2004 | WO2004021975A3 An improved process for the synthesis of pharmacologically active (z/e)-guggulsterones |
| 05/06/2004 | WO2004011663A9 Microbiological method for the production of 7 alpha-substituted 11 alpha-hydroxysteroids |
| 05/04/2004 | CA2098148C Process for the preparation of 16-alpha-methyl steroids |
| 05/04/2004 | CA2097678C Process for preparing a 11-keto steroid derivative |
| 04/29/2004 | US20040082556 Inhibitors of type 5 and type 3 17beta-hydroxysteroid dehydrogenase and methods for their use |
| 04/28/2004 | EP1412360A1 COMBINATION THERAPY OF AN SODm AND A CORTICOSTEROID FOR PREVENTION AND/OR TREATMENT OF INFLAMMATORY DISEASE |
| 04/22/2004 | WO2004033478A2 Fatty acid modified forms of glucocorticoids and their use as anti-inflammatory |
| 04/15/2004 | US20040071777 In hydrophilic cellulose ether, polyvinyl pyrrolidone, or polyethylene glycol; amorphous |
| 04/08/2004 | US20040068001 Using hydroxy-3-methylglutaryl/3-/ coenzyme inhibitor |
| 04/07/2004 | CN1144813C Noval pregnane derivatives without substituting group at 17šŒlpha position, itsapplication as medicine preparing method and intermediate thereof and related compounds |
| 04/01/2004 | US20040063677 Omega monounsaturated fatty acid derivativatized biologically active materials; drug delivery; drug resistance; bioavail-ability |
| 03/30/2004 | CA2243504C New 19-nor-pregnene derivatives |
| 03/24/2004 | EP1399464A1 Process to prepare 11beta, 17alpha, 21-trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione 21-acetate |
| 03/24/2004 | EP1399463A1 PROCESS TO PREPARE 11$g(b),17$g(a),21-TRIHYDROXY-6$g(a)-METHYLPREGNA-1,4-DIENE-3,20-DIONE 21-ACETATE |
| 03/18/2004 | WO2004021975A2 An improved process for the synthesis of pharmacologically active (z/e)-guggulsterones |
| 03/18/2004 | US20040053904 9-fluoro-11 beta-hydroxy-16 alpha-methyl-1,4-pregnadiene-3,20-dione 17-cyclopropanecarboxylate derivative for the treatment of respiratory system disorders such as bronchial asthma |
| 03/17/2004 | CN1142175C Sulfurization for oestrogen mixture |
| 03/10/2004 | EP1395603A1 Preparation of flumethasone and its 17-carboxyl androsten analogue |
| 03/10/2004 | EP1395544A1 Methods of making 21- 4'-(nitrooxyalkyl) benzoate] corticosteroid derivatives and intermediates useful in the synthesis thereof |
| 03/10/2004 | EP1303249B1 Antimycotic nail varnish composition |
| 03/10/2004 | CN1481246A Preventives/ermedies for inflammatory airway diseases |
| 03/10/2004 | CN1480139A Local medical compsn contg cholinergic medicine or calcium passage retardant |
| 03/04/2004 | US20040043974 Antiinflammatory agents; asthma; chronic obstructive pulmonary disease |
| 03/04/2004 | US20040043972 Autoimmune disease; antidiabetic agents |
| 03/03/2004 | EP1392320A1 17-METHYLENE-ANDROSTAN-3a-OL ANALOGS AS CRH INHIBITORS |
| 03/03/2004 | EP0998484B1 Method of identifying compounds having reduced systemic effects |
| 02/26/2004 | US20040038954 Method of treating inflammatory conditions with progesterone or progesterone analogs |
| 02/25/2004 | EP1390046A2 Treatment of neoplasms with viruses |
| 02/25/2004 | CN1477964A Treatment of neoplasms with viruses |
| 02/24/2004 | US6696592 Methods of making 21-[4′-(nitrooxyalkyl)benzoate] corticosteroid derivatives and intermediates useful in the synthesis thereof |
| 02/19/2004 | WO2003070745B1 Carbonate and carbamate modified forms of glucocorticoids |
| 02/18/2004 | EP1032396B1 Sterilization of glucocorticosteroids |
| 02/12/2004 | WO2004012742A1 Use of anecortave acetate for the protection of visual acuity in patients with age related macular degeneration |
| 02/12/2004 | US20040028752 Hemorrhoids therapy |
| 02/12/2004 | DE10233723A1 Preparation of 7 alpha-substituted 11 alpha-hydroxy-steroids, useful as precursors for new androgenic 7 alpha,17 alpha-substituted 11 beta-halo-steroids, by microbiological conversion of 7 alpha-substituted steroids |
| 02/12/2004 | CA2494211A1 Use of anecortave acetate for the protection of visual acuity in patients with age related macular degeneration |